Examination Report |
1 | Additional Representation Sheet | 09 Oct 2014 |
1 | Power of Attorney | 09 Oct 2014 |
1 | TM-1 | 09 Oct 2014 |
10 | Order | 08 Jun 2023 |
11 | Order | 08 Jun 2023 |
2 | Power of Attorney | 09 Oct 2014 |
2 | TM-1 | 09 Oct 2014 |
3 | Additional Representation Sheet | 09 Oct 2014 |
3 | TM-1 | 09 Oct 2014 |
4 | Reply to Exam Report (MIS-R) | 12 May 2016 |
5 | TM-O(NOTICE OF OPPOSITION) | 14 Jun 2018 |
6 | Journal Copy | 30 Jun 2018 |
7 | TM-O(NOTICE OF OPPOSITION) | 23 Jul 2018 |
8 | TM-O(NOTICE OF OPPOSITION) | 30 Aug 2018 |
9 | Letter of Withdrawal | 17 Oct 2018 |
1 | Hearing Notice (Show Cause) | 6046102 | 2737117 | 13 Mar 2018 |
2 | Tribunal Accepted Notice for : 2823953 | 6246417 | 2830826 | 18 Apr 2018 |
3 | Opposition Notice | 7135970 | 3316236 | 13 Oct 2018 |
4 | Opposition Notice | 7157878 | 3326144 | 17 Oct 2018 |
The application for Metzole was made on 09 October 2014.
The trademark applicant for Metzole is BLISS GVS PHARMA.
Metzole is applied in class(es) 5.
Application for Metzole is on Withdrawn stage.
Application Id allotted to Metzole is 2823953.
Trademark agent or attorney for the application is H. P. Associates.
Metzole filed with the Intellectual property office as a DEVICE.